Chemotherapy accelerates age-related development of tauopathy and results in loss of synaptic integrity and cognitive impairment
Open Access
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 79, 319-325
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute of the National Institutes of Health (R01CA208371, R01CA227064)
This publication has 53 references indexed in Scilit:
- Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's diseaseBrain Research, 2011
- Complications associated with chemotherapy in testicular cancer managementNature Reviews Urology, 2011
- Chemotherapy‐induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patientsHuman Brain Mapping, 2011
- Either Called “Chemobrain” or “Chemofog,” the Long-Term Chemotherapy-Induced Cognitive Decline in Cancer Survivors Is RealJournal of Pain and Symptom Management, 2011
- Mice with Cisplatin and Oxaliplatin-Induced Painful Neuropathy Develop Distinct Early Responses to Thermal StimuliMolecular Pain, 2009
- Neurologic complications of chemotherapy agentsCurrent Opinion in Neurology, 2007
- Brain Structure and Function Differences in Monozygotic Twins: Possible Effects of Breast Cancer ChemotherapyJournal of Clinical Oncology, 2007
- Mitochondrial Dysfunction and Dendritic Beading during Neuronal ToxicityJournal of Biological Chemistry, 2007
- Cognitive function in breast cancer patients prior to adjuvant treatmentBreast Cancer Research and Treatment, 2007
- Mitochondrial Oxidative Stress Causes Hyperphosphorylation of TauPLOS ONE, 2007